Neuroone Medical Technologies (NMTC) Change in Account Payables (2016 - 2026)
Neuroone Medical Technologies (NMTC) posted Change in Account Payables of $380240.0 for Q1 2026, up 186.42% on a QoQ basis from -$439992.0 in Q4 2025, and up 296.81% year-over-year from $95824.0 in Q1 2025.
Neuroone Medical Technologies (NMTC) Change in Account Payables (2016 - 2026) Analysis & Trends
Neuroone Medical Technologies' Change in Account Payables history runs 10 years deep, the most recent figure standing at $380240.0 for Q1 2026.
- Quarterly Change in Account Payables rose 296.81% year-over-year to $380240.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $99346.0 (up 39.97% YoY) and the FY2025 annual result came in at $239983.0, up 258.22% from the prior year.
- Change in Account Payables was $380240.0 for Q1 2026 at Neuroone Medical Technologies, up from -$439992.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $602635.0 in Q3 2022 and bottomed at -$439992.0 in Q4 2025.
- A 5-year average of $13194.2 and a median of -$14939.0 in 2024 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 3746.27% in 2025, while the deepest fall reached 2845.26% in 2025.
- Neuroone Medical Technologies' Change in Account Payables stood at -$154098.0 in 2022, then jumped by 151.61% to $79527.0 in 2023, then sank by 118.78% to -$14939.0 in 2024, then slumped by 2845.26% to -$439992.0 in 2025, then soared by 186.42% to $380240.0 in 2026.
- Business Quant data shows NMTC's Change in Account Payables at $380240.0 in Q1 2026, -$439992.0 in Q4 2025, and $526943.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.03 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.82 Bn | 125.95 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 108.46 Bn | 99.24 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.25 Bn | 66.79 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.55 Bn | 27.43 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.51 Bn | 26.22 Bn | 1.98 Bn | 221.00 Mn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | - |
| 10 | Neuroone Medical Technologies | 15.86 Mn | 13.06 Mn | 990,264.00 | 380,240.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 380,240.00 |
| Mar 31, 2026 | 380,240.00 |
| Dec 31, 2025 | -439,992.00 |
| Dec 31, 2025 | -439,992.00 |
| Sep 30, 2025 | 526,943.00 |
| Sep 30, 2025 | 526,943.00 |
| Jun 30, 2025 | -367,845.00 |
| Jun 30, 2025 | -367,845.00 |
| Mar 31, 2025 | 95,824.00 |
| Mar 31, 2025 | 95,824.00 |
| Dec 31, 2024 | -14,939.00 |
| Dec 31, 2024 | -14,939.00 |
| Sep 30, 2024 | 22,206.00 |
| Sep 30, 2024 | 22,206.00 |
| Jun 30, 2024 | -32,112.00 |
| Jun 30, 2024 | -32,112.00 |
| Mar 31, 2024 | -2,628.00 |
| Mar 31, 2024 | -2,628.00 |
| Dec 31, 2023 | 79,527.00 |
| Dec 31, 2023 | 79,527.00 |